Clinical Results of Decellularized Pulmonary Allografts for Right Ventricular Outflow Tract reconstruction during Ross Procedure. Where are we today?

Abstract

Sir Donald N. Ross established a new era to treat aortic valve disease by introducing the Ross procedure in 1967. The original technique was complex by implanting the pulmonary valve subcoronary into the aortic root with excellent long-term results. The limited part of this specific approach however, was meanly the right ventricular outflow tract (RVOT) reconstruction. Today, the golden standard is the use of a cryopreserved pulmonary allograft, however disadvantageous such as availability and immunogenic response can eventually lead to structural valve deterioration. Tissue engineering could help to create a valve with an excellent durability including remodelling, regeneration and growth potential for RVOT reconstruction. This article reflex a recent literature overview on clinical available solutions of correcting the RVOT by the use of decellularized pulmonary allografts.